Our PGX testing helps reduce trial and error in the medication-assisted treatment of a wide variety of conditions. Altered metabolic activity of one or more major CYP enzymatic pathways is highly prevalent and contributes to variable patient medication responses. Improve the efficacy of patient treatment plans using Luxor’s Pharmacogenetic testing results and reduce risks and costs associated with ineffective and/or potentially harmful medications.
Luxor PGX Testing can be ordered by medical specialty, by medication/medication class, and by individual gene-drug pairs.
Our pharmacogenetics testing delivers the following benefits:
Contact us if you would like a pharmacogenetics consultation.